IQVIA Holdings Inc at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 05:10PM GMT
Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research Analyst

All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.

Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO

Thank you.

Questions and Answers:

Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research Analyst

So you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.

Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO

Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot